Posts

Showing posts with the label drug development investment

Archive

Show more

Curia Boosts Sterile API Manufacturing with $4M Investment

Image
🕓 Estimated Reading Time: 4-5 minutes Overview Curia, a leading global contract research, development, and manufacturing organization (CRDMO), has announced a significant drug development investment of $4 million to bolster its sterile API manufacturing capabilities. This strategic capital injection is earmarked for its facility in Rensselaer, New York, and aims to enhance the company's capacity to produce active pharmaceutical ingredients (APIs), particularly high-potency APIs (HPAPIs) used in critical drug formulations. The move is a direct response to escalating client demand within the biopharmaceutical sector, signaling Curia's commitment to strengthening its role in the global pharmaceutical supply chain, according to a recent press release from the company. Background & Context The pharmaceutical industry relies heavily on a robust supply of high-quality active pharmaceutical ingredients. Sterile APIs are particularly crucial for drugs administered parenterally (e...

Popular posts from this blog

Toto Wolff Sells Mercedes F1 Stake George Kurtz Invests

ACND Approves Budget, Rates, and Infrastructure Grants

NVIDIA Earnings Impress AI Market Continues Surge

SwitchBot RGBICWW Smart LED Strip Arrives with Apple Home

WeRide Robotaxi Revenue Surges 836% Amid Global Expansion

Top Video Game Stocks to Research Right Now

Space-Based Network Market Projected to Reach $50 Billion

Cloudian Simplifies AI Data Storage Needs

Princeton Secures State Grant for First Multi-Purpose Field

Top Robot Vacuums Expert Picks for Your Home